Andrew Keat

3.9k total citations
93 papers, 2.7k citations indexed

About

Andrew Keat is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Andrew Keat has authored 93 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Rheumatology, 22 papers in Immunology and 21 papers in Hematology. Recurrent topics in Andrew Keat's work include Spondyloarthritis Studies and Treatments (49 papers), Rheumatoid Arthritis Research and Therapies (33 papers) and Autoimmune and Inflammatory Disorders Research (19 papers). Andrew Keat is often cited by papers focused on Spondyloarthritis Studies and Treatments (49 papers), Rheumatoid Arthritis Research and Therapies (33 papers) and Autoimmune and Inflammatory Disorders Research (19 papers). Andrew Keat collaborates with scholars based in United Kingdom, United States and India. Andrew Keat's co-authors include David Taylor‐Robinson, Bethan Thomas, Ian Rowe, Brenda Thomas, J. Dixey, Rodney Hughes, Chris Sonnex, Rupa Bessant, C B Gilroy and G. D. Pegrum and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of the Rheumatic Diseases.

In The Last Decade

Andrew Keat

91 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Keat United Kingdom 30 1.7k 763 612 393 331 93 2.7k
R. von Essen Finland 24 790 0.5× 402 0.5× 269 0.4× 605 1.5× 207 0.6× 58 2.4k
Reijo Luukkainen Finland 29 1.3k 0.8× 812 1.1× 481 0.8× 239 0.6× 188 0.6× 72 3.0k
L W Poulter United Kingdom 32 539 0.3× 1.4k 1.9× 149 0.2× 458 1.2× 232 0.7× 75 3.3k
M. Rybojad France 28 761 0.4× 973 1.3× 491 0.8× 925 2.4× 525 1.6× 144 3.2k
William H. Kutteh United States 40 749 0.4× 2.3k 3.0× 753 1.2× 388 1.0× 33 0.1× 140 5.5k
Ali Akbar Amirzargar Iran 26 379 0.2× 1.2k 1.5× 173 0.3× 562 1.4× 159 0.5× 106 2.3k
Volker Schuster Germany 29 289 0.2× 343 0.4× 430 0.7× 399 1.0× 83 0.3× 118 2.9k
Dirk Holzinger Germany 33 526 0.3× 1.5k 1.9× 1.1k 1.9× 339 0.9× 94 0.3× 85 3.6k
Daniel Mimouni Israel 36 1.3k 0.7× 290 0.4× 393 0.6× 889 2.3× 721 2.2× 153 4.2k
Carlos R. Abramowsky United States 31 353 0.2× 781 1.0× 196 0.3× 629 1.6× 79 0.2× 138 3.9k

Countries citing papers authored by Andrew Keat

Since Specialization
Citations

This map shows the geographic impact of Andrew Keat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Keat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Keat more than expected).

Fields of papers citing papers by Andrew Keat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Keat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Keat. The network helps show where Andrew Keat may publish in the future.

Co-authorship network of co-authors of Andrew Keat

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Keat. A scholar is included among the top collaborators of Andrew Keat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Keat. Andrew Keat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macfarlane, Gary J., Maxwell S. Barnish, Elizabeth A. Jones, et al.. (2015). The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment. BMC Musculoskeletal Disorders. 16(1). 347–347. 35 indexed citations
2.
Pathan, Ejaz, Sonya Abraham, R H Withrington, et al.. (2012). Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Annals of the Rheumatic Diseases. 72(9). 1475–1480. 98 indexed citations
3.
Sieper, Joachim, Shankar Srinivasan, Omid Zamani, et al.. (2012). Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Annals of the Rheumatic Diseases. 72(10). 1621–1627. 94 indexed citations
4.
Stone, Millicent, Emma Pomeroy, Andrew Keat, et al.. (2008). Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Lara D. Veeken. 47(8). 1213–1218. 39 indexed citations
5.
Keat, Andrew, et al.. (2007). Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis. Lara D. Veeken. 47(4). 481–483. 42 indexed citations
6.
Keat, Andrew, et al.. (2006). A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma. Nature Clinical Practice Rheumatology. 2(12). 686–690. 9 indexed citations
7.
Keat, Andrew, Nick Barkham, A K Bhalla, et al.. (2005). BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Lara D. Veeken. 44(7). 939–947. 71 indexed citations
8.
Keat, Andrew. (1999). Reactive Arthritis. Advances in experimental medicine and biology. 455. 201–206. 4 indexed citations
9.
Taylor‐Robinson, David & Andrew Keat. (1999). Septic and aseptic arthritis: a continuum?. Best Practice & Research Clinical Rheumatology. 13(1). 179–192. 6 indexed citations
10.
Steuer, A & Andrew Keat. (1997). Perioperative use of methotrexate--a survey of clinical practice in the UK. Lara D. Veeken. 36(9). 1009–1011. 13 indexed citations
11.
Keat, Andrew. (1995). ABC of Rheumatology: SPONDYLOARTHROPATHIES. BMJ. 310(6990). 1321–1324. 7 indexed citations
12.
Keat, Andrew & Rod Hughes. (1993). Infectious agents in reactive arthritis. Current Opinion in Rheumatology. 5(4). 414–419. 7 indexed citations
13.
Taylor‐Robinson, David, C B Gilroy, Bethan Thomas, & Andrew Keat. (1992). Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. The Lancet. 340(8811). 81–82. 155 indexed citations
14.
Keat, Andrew. (1992). Extra-genital Chlamydia trachomatis infection as sexually-acquired reactive arthritis. Journal of Infection. 25. 47–49. 3 indexed citations
16.
Wordsworth, B P, Rodney Hughes, I. Allan, Andrew Keat, & J I Bell. (1990). CHLAMYDIAL DNA IS ABSENT FROM THE JOINTS OF PATIENTS WITH SEXUALLY ACQUIRED REACTIVE ARTHRITIS. Lara D. Veeken. 29(3). 208–210. 37 indexed citations
17.
Dekker-Saeys, A. J. & Andrew Keat. (1990). Follow-up Study of Ankylosing Spondylitis over a Period of 12 Years (1977-1989). Scandinavian Journal of Rheumatology. 19(sup87). 120–121. 11 indexed citations
18.
Moyle, G, Samantha Barton, J Midgley, et al.. (1990). Gonococcal arthritis caused by auxotype P in a man with HIV infection.. Sexually Transmitted Infections. 66(2). 91–92. 12 indexed citations
19.
Harcourt-Webster, J N, et al.. (1990). Synovium in AIDS: a postmortem study.. BMJ. 300(6734). 1239–1240. 9 indexed citations
20.
Husby, Gunnar, Naoyuki Tsuchiya, Peter Schwimmbeck, et al.. (1988). Synovial Expression of HLA-B27 Related Antigens in Ankylosing Spodilitis. Scandinavian Journal of Rheumatology. 17(sup76). 23–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026